Anika Therapeutics (ANIK) Amortization of Deferred Charges (2019 - 2021)
Anika Therapeutics (ANIK) reported Amortization of Deferred Charges of $400000.0 for Q3 2021, down 2.68% year-over-year from $411000.0 in Q3 2020, and down 21.1% quarter-over-quarter from $507000.0 in Q2 2021.
Anika Therapeutics (ANIK) Amortization of Deferred Charges (2019 - 2021) Analysis & Trends
Anika Therapeutics (ANIK) has 3 years of Amortization of Deferred Charges data on file, last reported at $400000.0 in Q3 2021.
- Amortization of Deferred Charges for Q3 2021 came in at $400000.0, down 2.68% year-over-year; the trailing twelve-month figure through Sep 2021 was $1.7 million (up 18.95% YoY), and the FY2020 annual result was $1.5 million, up 29.86% from the prior year.
- Amortization of Deferred Charges slipped to $400000.0 in Q3 2021 per ANIK's latest filing, from $507000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $507000.0 in Q2 2021 and troughed at $289000.0 in Q3 2019.
- A 3-year average of $365636.4 and a median of $385000.0 in 2020 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2020 and 2021: Amortization of Deferred Charges jumped 42.21% in 2020, then fell 2.68% in 2021.
- A 3-year view of Amortization of Deferred Charges shows it stood at $299000.0 in 2019, then surged by 32.11% to $395000.0 in 2020, then gained by 1.27% to $400000.0 in 2021.
- Business Quant data shows ANIK's Amortization of Deferred Charges at $400000.0 in Q3 2021, $507000.0 in Q2 2021, and $405000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Anika Therapeutics | 197.89 Mn | 131.10 Mn | 19.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 400,000.00 |
| Sep 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 507,000.00 |
| Jun 30, 2021 | 507,000.00 |
| Mar 31, 2021 | 405,000.00 |
| Mar 31, 2021 | 405,000.00 |
| Dec 31, 2020 | 395,000.00 |
| Dec 31, 2020 | 395,000.00 |
| Sep 30, 2020 | 411,000.00 |
| Sep 30, 2020 | 411,000.00 |
| Jun 30, 2020 | 385,000.00 |
| Jun 30, 2020 | 385,000.00 |
| Mar 31, 2020 | 340,000.00 |
| Mar 31, 2020 | 340,000.00 |
| Dec 31, 2019 | 299,000.00 |
| Dec 31, 2019 | 299,000.00 |
| Sep 30, 2019 | 289,000.00 |
| Sep 30, 2019 | 289,000.00 |
| Jun 30, 2019 | 294,000.00 |
| Jun 30, 2019 | 294,000.00 |